FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096483916> ?p ?o ?g. }

• W2096483916 endingPage "167" @default.
• W2096483916 startingPage "160" @default.
• W2096483916 abstract "Purpose To determine whether chitosan hydrogel nanoparticles loaded with vascular endothelial growth factor (VEGF) peptides (81–91 fragments) capable of targeting the ischemic myocardium enhance angiogenesis and promote therapeutic effects and whether radionuclide image–guided dosage control is feasible. Materials and Methods Experimental procedures and protocols were approved by the Institutional Animal Care and Use Committee. Rats (n = 32, eight per group) were subjected to myocardial ischemia (control group) and received chitosan hydrogel nanoparticles with VEGF165 proteins (chitosan VEGF) or VEGF81–91 peptides (chitosan peptides) via apical puncture. Ischemic hearts receiving chitosan without angiogenic factors served as the chitosan control. Myocardial perfusion was examined 7 days after surgery by using technetium 99m (99mTc) tetrofosmin (37 MBq) autoradiography, and changes in vascular density with immunohistochemical staining were reviewed. Kruskal-Wallis test and Bonferroni corrected Mann-Whitney U test were used for multiple comparisons. Wilcoxon signed rank test was used to compare myocardial retention of 99mTc chitosan. Results Thirty minutes of myocardial ischemia resulted in perfusion defects (median, 54%; interquartile range [IQR], 41%–62%). Chitosan VEGF decreased perfusion defect extent (median, 68%; IQR, 63%–73%; P = .006 vs control) and increased vascular density (median, 81 vessels per high-power field; IQR, 72–100; P = .009 vs control). Administration of chitosan peptides reduced the degree of perfusion defects (median, 66%; IQR, 62%–73%; P = .006 vs control) and increased vascular density (median, 82 vessels; IQR, 78–92; P = .006 vs control). The effects of chitosan peptides on perfusion and vascular density were comparable to those seen with chitosan VEGF proteins (P = .713 and P = .833, respectively). Chitosan radiolabeled with 99mTc was administered twice at reperfusion with a 1-hour interval to determine whether image-guided dosage control is feasible. The hearts initially retained 4.6% (IQR, 4.1%–5.0%) of 99mTc chitosan administered and 9.2% (IQR, 6.6%–12.7%; P = .068) with subsequent injection. Conclusion VEGF peptides have angiogenic potential and resulted in therapeutic effectiveness. Adjunct use of single photon emission computed tomography was also demonstrated for individualized treatment of myocardial ischemia by further tailoring the therapeutic dosing. © RSNA, 2014 Online supplemental material is available for this article." @default.
• W2096483916 created "2016-06-24" @default.
• W2096483916 creator A5006339259 @default.
• W2096483916 creator A5011091703 @default.
• W2096483916 creator A5020734351 @default.
• W2096483916 creator A5027473085 @default.
• W2096483916 creator A5032703429 @default.
• W2096483916 creator A5043921996 @default.
• W2096483916 creator A5055103547 @default.
• W2096483916 creator A5074421507 @default.
• W2096483916 creator A5079729400 @default.
• W2096483916 creator A5086691038 @default.
• W2096483916 date "2014-10-01" @default.
• W2096483916 modified "2023-09-23" @default.
• W2096483916 title "Peptide-loaded Nanoparticles and Radionuclide Imaging for Individualized Treatment of Myocardial Ischemia" @default.
• W2096483916 cites W177050335 @default.
• W2096483916 cites W1968255930 @default.
• W2096483916 cites W1994322982 @default.
• W2096483916 cites W1996246992 @default.
• W2096483916 cites W2003716428 @default.
• W2096483916 cites W2008591914 @default.
• W2096483916 cites W2014764992 @default.
• W2096483916 cites W2014815776 @default.
• W2096483916 cites W2018385626 @default.
• W2096483916 cites W2036079743 @default.
• W2096483916 cites W2037590348 @default.
• W2096483916 cites W2056514401 @default.
• W2096483916 cites W2062047808 @default.
• W2096483916 cites W2063318887 @default.
• W2096483916 cites W2065334464 @default.
• W2096483916 cites W2070003597 @default.
• W2096483916 cites W2070049579 @default.
• W2096483916 cites W2079273552 @default.
• W2096483916 cites W2081510823 @default.
• W2096483916 cites W2082157250 @default.
• W2096483916 cites W2085061661 @default.
• W2096483916 cites W2085362322 @default.
• W2096483916 cites W2103227975 @default.
• W2096483916 cites W2112318295 @default.
• W2096483916 cites W2140003426 @default.
• W2096483916 cites W2141046053 @default.
• W2096483916 cites W2142401146 @default.
• W2096483916 cites W2144075923 @default.
• W2096483916 cites W2146800179 @default.
• W2096483916 cites W2155090369 @default.
• W2096483916 cites W2163886094 @default.
• W2096483916 doi "https://doi.org/10.1148/radiol.14132942" @default.
• W2096483916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24927328" @default.
• W2096483916 hasPublicationYear "2014" @default.
• W2096483916 type Work @default.
• W2096483916 sameAs 2096483916 @default.
• W2096483916 citedByCount "22" @default.
• W2096483916 countsByYear W20964839162015 @default.
• W2096483916 countsByYear W20964839162016 @default.
• W2096483916 countsByYear W20964839162017 @default.
• W2096483916 countsByYear W20964839162018 @default.
• W2096483916 countsByYear W20964839162020 @default.
• W2096483916 countsByYear W20964839162021 @default.
• W2096483916 countsByYear W20964839162022 @default.
• W2096483916 crossrefType "journal-article" @default.
• W2096483916 hasAuthorship W2096483916A5006339259 @default.
• W2096483916 hasAuthorship W2096483916A5011091703 @default.
• W2096483916 hasAuthorship W2096483916A5020734351 @default.
• W2096483916 hasAuthorship W2096483916A5027473085 @default.
• W2096483916 hasAuthorship W2096483916A5032703429 @default.
• W2096483916 hasAuthorship W2096483916A5043921996 @default.
• W2096483916 hasAuthorship W2096483916A5055103547 @default.
• W2096483916 hasAuthorship W2096483916A5074421507 @default.
• W2096483916 hasAuthorship W2096483916A5079729400 @default.
• W2096483916 hasAuthorship W2096483916A5086691038 @default.
• W2096483916 hasConcept C119060515 @default.
• W2096483916 hasConcept C126322002 @default.
• W2096483916 hasConcept C146957229 @default.
• W2096483916 hasConcept C167734588 @default.
• W2096483916 hasConcept C185592680 @default.
• W2096483916 hasConcept C2777025900 @default.
• W2096483916 hasConcept C2779732960 @default.
• W2096483916 hasConcept C2780394083 @default.
• W2096483916 hasConcept C2989005 @default.
• W2096483916 hasConcept C541997718 @default.
• W2096483916 hasConcept C55493867 @default.
• W2096483916 hasConcept C71924100 @default.
• W2096483916 hasConceptScore W2096483916C119060515 @default.
• W2096483916 hasConceptScore W2096483916C126322002 @default.
• W2096483916 hasConceptScore W2096483916C146957229 @default.
• W2096483916 hasConceptScore W2096483916C167734588 @default.
• W2096483916 hasConceptScore W2096483916C185592680 @default.
• W2096483916 hasConceptScore W2096483916C2777025900 @default.
• W2096483916 hasConceptScore W2096483916C2779732960 @default.
• W2096483916 hasConceptScore W2096483916C2780394083 @default.
• W2096483916 hasConceptScore W2096483916C2989005 @default.
• W2096483916 hasConceptScore W2096483916C541997718 @default.
• W2096483916 hasConceptScore W2096483916C55493867 @default.
• W2096483916 hasConceptScore W2096483916C71924100 @default.
• W2096483916 hasIssue "1" @default.
• W2096483916 hasLocation W20964839161 @default.
• W2096483916 hasLocation W20964839162 @default.
• W2096483916 hasOpenAccess W2096483916 @default.

• next